Wellington Management Group LLP Purchases 799,761 Shares of HCA Healthcare, Inc. $HCA

Wellington Management Group LLP grew its position in HCA Healthcare, Inc. (NYSE:HCA) by 20.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,707,473 shares of the company’s stock after purchasing an additional 799,761 shares during the period. Wellington Management Group LLP owned approximately 2.17% of HCA Healthcare worth $1,835,397,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Nomura Asset Management Co. Ltd. raised its holdings in shares of HCA Healthcare by 6.2% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after buying an additional 3,724 shares during the period. Sunbelt Securities Inc. grew its position in HCA Healthcare by 171.7% in the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after acquiring an additional 3,945 shares during the last quarter. Liberty Wealth Management LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at $1,905,000. Arrowstreet Capital Limited Partnership increased its stake in HCA Healthcare by 11.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares during the period. Finally, Sei Investments Co. boosted its position in HCA Healthcare by 27.5% in the 1st quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock valued at $221,380,000 after buying an additional 100,764 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $417.57 on Friday. The business has a fifty day moving average of $401.08 and a 200 day moving average of $441.46. The firm has a market capitalization of $90.40 billion, a price-to-earnings ratio of 13.98, a price-to-earnings-growth ratio of 1.46 and a beta of 1.10. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same period last year, the business posted $6.84 earnings per share. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is presently 10.45%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HCA. UBS Group decreased their target price on HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a research report on Monday, July 27th. Wells Fargo & Company upped their target price on HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a report on Monday, August 3rd. Oppenheimer decreased their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research note on Monday, July 27th. Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a research report on Tuesday, July 7th. Finally, Morgan Stanley dropped their target price on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research note on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.